The standard of truth was tau pathology consistent with Braak Stages V and VI or high Alzheimer’s disease neuropathological change (ADNC) consistent with Braak Stages V and VI NFT pathology and extensive Aβ plaque pathology. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.